pagets disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Aged over 18 years old, male or female; 2. patients need to have a relatively single clinical features and demographic common features; 3. Subjects fully understand the patient's notice, signed informed consent; 4. The duration of more than 3 months; 5. According to a comprehensive diagnosis, the diagnosis of the disease.
Exclusion criteria
Exclusion criteria: 1. Those who refuse to sign an informed consent belong to the category of the standard; 2. Failure to sign the informed consent will make the study less feasible; 3. The presence of comorbidities or co-morbidities, poor general condition, and serious illness leading to death before the end of the clinical trial falls within the criteria; 4. Exclusion criteria restrict certain cases to enrollment. The purpose is to increase the safety and feasibility of the study, including "informed consent" as an exclusion criterion and excluding cases that refused to sign an informed consent, in line with medical ethics requirements.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Histopathology Biopsy; | — |
Countries
China
Contacts
Shanghai Skin Disease Hospital